Cargando…

SABR in oligometastatic breast cancer: Current status and future directions

Oligometastatic breast cancer (OMBC) is a heterogeneous disease with intrinsic biological diversity. It is increasingly accepted in clinical practice that patients with OMBC could be treated with the expectation of long-term disease remission. Local ablative treatments, such as radiotherapy or surge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stewart, Rachel, White, Michelle, Tan, Jennifer, Siva, Shankar, Karroum, Lama, David, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579150/ https://www.ncbi.nlm.nih.gov/pubmed/34739890 http://dx.doi.org/10.1016/j.breast.2021.10.009

Ejemplares similares

Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions
por: David, Steven, et al.
Publicado: (2022)

Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
por: David, Steven, et al.
Publicado: (2019)

Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer
por: Mercier, Carole, et al.
Publicado: (2022)

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)
por: Hasan, Hamza, et al.
Publicado: (2020)

On the reduction of aperture complexity in kidney SABR
por: Gaudreault, Mathieu, et al.
Publicado: (2021)

Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
por: Alomran, Reem, et al.
Publicado: (2021)

First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac
por: Janssen, Tomas M., et al.
Publicado: (2022)

Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience
por: Sánchez-Iglesias, Ángel L., et al.
Publicado: (2022)

Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)

SABR for Synchronous Bilateral Primary Renal Cell Carcinoma: A Case Report
por: Ali, Muhammad, et al.
Publicado: (2022)

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
por: Palma, David A, et al.
Publicado: (2012)

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach
por: Comito, Tiziana, et al.
Publicado: (2014)

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
por: Palma, David A., et al.
Publicado: (2020)

Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions
por: Couñago, Felipe, et al.
Publicado: (2019)

Assessing organ at risk position variation and its impact on delivered dose in kidney SABR
por: Gaudreault, Mathieu, et al.
Publicado: (2022)

Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer
por: Alberto, Matthew, et al.
Publicado: (2022)

Independent review of 4DCT scans used for SABR treatment planning
por: Antony, Rachitha, et al.
Publicado: (2020)

Hydroxychloroquine in nephrology: current status and future directions
por: Rao, Indu Ramachandra, et al.
Publicado: (2023)

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
por: Dhaliwal, Inderdeep, et al.
Publicado: (2022)

Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial
por: Olson, Robert, et al.
Publicado: (2020)

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
por: Palma, David A., et al.
Publicado: (2019)

Current and Future Directions of Breast MRI
por: Houser, Margaret, et al.
Publicado: (2021)

Radiation Metabolomics: Current Status and Future Directions
por: Menon, Smrithi S., et al.
Publicado: (2016)

Ovarian cancer screening—Current status, future directions()
por: Menon, Usha, et al.
Publicado: (2014)

Quantification of hyperpolarisation efficiency in SABRE and SABRE-Relay enhanced NMR spectroscopy
por: Richardson, Peter M., et al.
Publicado: (2018)

Management of Hepatocellular Carcinoma: Current Status and Future Directions
por: Au, Jennifer S., et al.
Publicado: (2015)

Colletotrichum – current status and future directions
por: Cannon, P.F., et al.
Publicado: (2012)

Checkpoint blockade in the treatment of breast cancer: current status and future directions
por: Wein, Lironne, et al.
Publicado: (2018)

Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future Directions
por: Gallivanone, Francesca, et al.
Publicado: (2022)

Artificial Intelligence Applications in Breast Imaging: Current Status and Future Directions
por: Taylor, Clayton R., et al.
Publicado: (2023)

Antibody–Drug Conjugates in Breast Cancer: Current Status and Future Directions
por: Mark, Cynthia, et al.
Publicado: (2023)

Local ablative therapies in oligometastatic NSCLC-upfront or outback?—a narrative review
por: Tjong, Michael C., et al.
Publicado: (2021)

Surgical treatment in oligometastatic breast cancer
por: Vargas, Catalina, et al.
Publicado: (2019)

Oligometastatic Breast Cancer: How to Manage It?
por: Barberi, Vittoria, et al.
Publicado: (2021)

SABRE : sistema de reservaciones para agencias de viajes
por: Mata Hernández, Elizabeth
Publicado: (1999)

SABRE: a system for the assessment of body radioactivity ; 2, main features of SABRE 3
por: Venn, J B
Publicado: (1978)

Proton Radiotherapy for Patients With Oligometastatic Breast Cancer Involving the Sternum
por: Johnson, Andrew, et al.
Publicado: (2021)

Network Security: Current Status and Future Directions
por: Douligeris, Christos
Publicado: (2007)

Current status and future directions of personalized medicine
por: Bryce, Alan Haruo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qjcif1apa8gkv9rigm9gr756p2